CMS released the CY2027 Medicare Physician Fee Schedule proposed rule on July 14, 2026, with comments open through September 14.[1][2] Most of the coverage has focused, reasonably, on the payment cut: the conversion factor for clinicians outside advanced payment models falls about 1.7 percent.[3] But for anyone whose model depends on remote physiological monitoring, the consequential news is not the top-line number. It is a set of proposals that would change how RPM can be delivered and billed — and what they signal about where CMS wants the money to go.
Three provisions matter most, and each should be read as worded rather than as feared.
The first would restrict payment for RPM and remote therapeutic monitoring to services performed by clinical staff employed by the billing practice, and not by contractors.[1] Vendors could still supply the devices, connectivity, dashboards, and analytics; what they could no longer supply is the outsourced clinical labor that monitors the data and bills for it. CMS's stated concern is that outsourced monitoring "can fragment care" and dilute the billing practitioner's involvement.[4] The practical effect, if finalized, is that the many RPM programs built on third-party monitoring staff would have to bring that labor in-house or end the program.[5]
The second would revalue the RPM and RTM codes downward. CMS proposes to crosswalk the setup and device-supply codes to lower-paid analogues and to strip the practice-expense inputs from the treatment-management codes, on the reasoning that the devices cost less than the agency first estimated.[3] CMS has not published the resulting dollar figures or relative value units, so any specific percentage would be invented; the direction, however, is unambiguous, and it is down.[3]
The third would require a face-to-face initiating visit before monitoring begins.[1] This is worth stating carefully, because it is easy to overstate: the visit may be furnished in person or via telehealth.[4] It is not an in-person mandate. It is a requirement that a real clinical encounter, with an established patient, precede the monitoring — closing the pattern the HHS Inspector General flagged in 2024, when it found that 43 percent of Medicare enrollees receiving RPM did not get all of the service's required components.[6] Read alongside the proposed extension of the established-patient requirement to RTM, and a request for comment on collapsing seventeen monitoring codes into four bundled ones, the through-line is clear: CMS is trying to make fee-for-service monitoring harder to bill loosely.[3]
We think the more important document is the one CMS published seven months earlier. In December 2025 the Innovation Center announced the ACCESS Model, which began operating on July 1, 2026, and which pays for chronic-care outcomes rather than for the monitoring service.[7] The CY2027 fee schedule, read next to ACCESS, is not simply a crackdown. It is one half of a deliberate redirection. The fee schedule frames its own purpose in the language of prevention — CMS writes that it aims to "shift the U.S. healthcare system toward a focus on preventive rather than reactive medicine" — and it pairs the RPM restrictions with a set of incentives pulling the other way: a new modifier paying a premium for longitudinal care, a larger one for clinicians in accountable-care organizations, and a substantial overhaul of the Shared Savings Program.[1][3] The same rule that makes it harder to bill for monitoring makes it more rewarding to be accountable for outcomes.
For a provider, the strategic reading matters more than the line-item one. If a monitoring program's economics depend on fee-for-service RPM billing — on the codes, the outsourced staffing, the per-device revenue — this proposed rule is a warning that the ground under that model is eroding, and that congressional pushback, though real, is a fragile thing to build on.[8] If instead the program's economics depend on avoiding an expensive event — a readmission a risk contract would otherwise absorb — the same rule is close to irrelevant, because the value was never in the monitoring code. It was in the outcome, and the outcome is exactly what CMS is now building a payment lane to reward.
That is the practical implication we would put in front of a population-health leader: do not organize a prevention program around the reimbursement coupon, because the coupon is being clipped. Organize it around the avoided cost and the provable outcome, because that is where both the risk contract and the Innovation Center are heading. The fee schedule is a proposed rule and may change before it is final. The direction of travel will not.
Sources
- CMS, "Calendar Year (CY) 2027 Medicare Physician Fee Schedule Proposed Rule" (fact sheet), July 14, 2026 — cms.gov
- Federal Register, CY 2027 PFS Proposed Rule (CMS-1848-P), 91 FR 43842, July 16, 2026 — federalregister.gov
- Holland & Knight, "CMS Issues CY 2027 Medicare Physician Fee Schedule Proposed Rule," July 2026 — hklaw.com
- McDermott Will & Schulte, "Remote monitoring at a crossroads: CMS proposes sweeping changes," July 16, 2026 — mcdermottlaw.com
- Fierce Healthcare, "CMS proposal to block third-party vendors will upend remote monitoring services," July 16, 2026 — fiercehealthcare.com
- HHS Office of Inspector General, "Additional Oversight of Remote Patient Monitoring in Medicare Is Needed" (OEI-02-23-00260), Sept. 2024 — oig.hhs.gov
- CMS Innovation Center, "ACCESS Model" — cms.gov
- Healthcare IT News, "ATA Action flags 'stark contradiction' in CMS Physician Fee Schedule," July 22, 2026 — healthcareitnews.com
